Anticalin® proteins are artifical proteins derived from human lipocalins. They have a diversifiable amino acid sequence that results in four loops. These loops assemble into a cup like structure that can bind both smaller and larger molecules.

Anticalin proteins can be used in a similar fashion to monoclonal antibodies (mAbs) but they are not structurally related and much smaller with a molecular mass around 25 kDa and a size of about 180 amino acids. Since they are smaller than mAbs they may be delivered via non-injectable routes such as inhalation via the lung.




  • Join us

    AstraZeneca is one of the world’s most exciting bio-pharmaceutical companies. Be inspired by the possibilities of science to make a difference and discover what you can do.


  • Partner with us

    We know that innovation doesn’t happen in isolation, so we partner with others to access the best science and contribute complementary technologies, know-how and molecules.


  • Learn about us

    Our IMED Biotech unit is committed to driving scientific advances in small molecules, oligonucleotides and other emerging technology platforms to push the boundaries of medical science.